No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
PRVA240621C22500
- 0.24
- 0.000.00%
15min DelayClose Jun 20 11:40 ET
0.00High0.00Low
0.24Open0.24Pre Close0 Volume221 Open Interest22.50Strike Price0.00Turnover420.55%IV35.52%PremiumJun 21, 2024Expiry Date0.00Intrinsic Value100Multiplier1DDays to Expiry0.24Extrinsic Value100Contract SizeAmericanOptions Type0.1323Delta0.0537Gamma69.92Leverage Ratio-0.2398Theta0.0001Rho9.25Eff Leverage0.0020Vega
Intraday
- 5D
- Daily
News
Privia Health(PRVA.US) Director Buys US$6,006 in Common Stock
$Privia Health(PRVA.US)$ Director Boehler Adam purchased 364 shares of common stock on Jun 11, 2024 at an average price of $16.5 for a total value of $6,006.Source: Announcement What is statement of c
Capital Allocation Trends At Privia Health Group (NASDAQ:PRVA) Aren't Ideal
Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Ideally, a business will show two trends; firstly a growing return on capital employed (ROCE) and sec
Insider Stock Buying Reaches US$9.30m On Privia Health Group
Privia Health(PRVA.US) Director Buys US$87,549 in Common Stock
$Privia Health(PRVA.US)$ Director Boehler Adam purchased 5,306 shares of common stock on May 29, 2024 at an average price of $16.5 for a total value of $87,549.Source: Announcement What is statement o
Privia Health to Participate in the William Blair Growth Stock Conference
ARLINGTON, Va., May 30, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) today announced that its management team plans to present at the 44th Annual William Blair Growth Stock Conference on Wednesday,
Insiders Buying Hilton Worldwide And 2 Other Stocks
Although U.S. stocks closed lower on Wednesday, there were a few notable insider trades.When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the st
Comments
Jefferies analysts predict a shift to value-based care as a defining trend in healthcare. They foresee Astrana Health's unique model gaining attention, closing the valuation gap with popular peers. Privia is also praised for its balanced, sustainable earnings growth.
Jefferies Cautious on Value Based Care Providers; Favors ASTH, PRVA, TOIPrivia Health's CEO, Parth Mehrotra, welcomes Edward C. Fargis, citing his vast experience in corporate governance, compliance and strategic transactions. Fargis is eager to contribute to a profitable growth strategy benefiting stakeholders.
1 | Below is a look at the top insider trades with the biggest value in the past week.
The largest insider trading of this week, which is a sale order of 24,819,473 units, worth over $536.47M, was made by Privia Health director, Daniel Jeffrey Bernstein, on May 10, 2023.
In total, Daniel has made about 4 transactions worth about $1.04B over 2 years at Privia Health Group. The current estimated net worth of Privi...
The largest insider trading of this week, which is a sale order of 24,819,473 units, worth over $536.47M, was made by Privia Health director, Daniel Jeffrey Bernstein, on May 10, 2023.
In total, Daniel has made about 4 transactions worth about $1.04B over 2 years at Privia Health Group. The current estimated net worth of Privi...
13
2
Gapping up
In reaction to earnings/guidance:
• $ChargePoint(CHPT.US$ +2.8%, $Designer Brands(DBI.US$ +1.8%, $Donaldson(DCI.US$ +0.7%
Other news:
• $Cepton(CPTN.US$ +9.2% (receives non-bindingLolfor a $100mln investment from Koito Manufacturing)
• $Sorrento Therapeutics(SRNE.US$ +7.2% (receives FDA Fast Track Designation for SP-103(Lidocaine Topical System) 5.4%)
• $Mereo BioPharma(MREO.US$ +6.7% (sends letter to Rubric Capital...
In reaction to earnings/guidance:
• $ChargePoint(CHPT.US$ +2.8%, $Designer Brands(DBI.US$ +1.8%, $Donaldson(DCI.US$ +0.7%
Other news:
• $Cepton(CPTN.US$ +9.2% (receives non-bindingLolfor a $100mln investment from Koito Manufacturing)
• $Sorrento Therapeutics(SRNE.US$ +7.2% (receives FDA Fast Track Designation for SP-103(Lidocaine Topical System) 5.4%)
• $Mereo BioPharma(MREO.US$ +6.7% (sends letter to Rubric Capital...
9
Upgrades
• $Agora(API.US$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $12.50
• $argenx SE(ARGX.US$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $375 (from $278)
• $Idacorp(IDA.US$ : Wells Fargo Upgrades to Equal Weight from Underweight - PT $110 (from $108)
• $Jakks Pacific(JAKK.US$ : BMO Capital Upgrades to Outperform from Market Perform - PT $21
• $Coca-Cola FEMSA(KOF.US$ : Barclays Upgrades to Overweight from Equal Wei...
• $Agora(API.US$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $12.50
• $argenx SE(ARGX.US$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $375 (from $278)
• $Idacorp(IDA.US$ : Wells Fargo Upgrades to Equal Weight from Underweight - PT $110 (from $108)
• $Jakks Pacific(JAKK.US$ : BMO Capital Upgrades to Outperform from Market Perform - PT $21
• $Coca-Cola FEMSA(KOF.US$ : Barclays Upgrades to Overweight from Equal Wei...
12
2
Read more